注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Aspira Women's Health Inc致力於發現、開發和利用檢測選項和生物分析解決方案。其產品包括OVA1和Ovra、OVA1plus、Aspira GenetiX和Aspira Synergy。OVA1是一種血液檢測產品,旨在當醫生進行獨立臨床試驗計畫對其進行手術時幫助進一步評估卵巢附件腫塊女性患惡性腫瘤的可能性,Ovra旨在保持OVA1的高度敏感性。OVA1plus是對處於中等風險範圍的OVA1測試結果進行的反射測試。Aspira GenetiX是一種針對婦科癌症風險的基因測試,重點關注女性生殖癌症,包括乳腺癌、卵巢癌、子宮內膜癌、子宮癌和宮頸癌。Aspira Synergy是一個基於雲科技的成套技術轉移解決方案,為臨床實驗室提供從樣本採集到定制白標籤報告的端到端解決方案,以實現其產品的內部測試。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Celeste R. Fralick | 63 | 2022 | Independent Director |
Jannie Herchuck | - | 2023 | Independent Director |
Daniel W. Chan | - | 2006 | Member of Scientific Advisory Board |
Jannie P. Herchuk | 60 | 2023 | Independent Chair of the Board |
Tamika Sea | - | 2023 | Member of Clinical Advisory Board |
Winfred Parnell | - | 2023 | Independent Director |
Stefanie L. Cavanaugh | 59 | 2023 | Independent Director |
Nisha Garg | - | 2023 | Member of Clinical Advisory Board |
Levi S. Downs | - | 2023 | Member of Clinical Advisory Board |
Nicole Sandford | 53 | 2021 | CEO & Director |
Farr R. Nezhat | - | - | Member of Scientific Advisory Board |
Donald G. Munroe | 67 | 2011 | Member of Scientific Advisory Board |
Robert E. Bristow | - | - | Member of Scientific Advisory Board |
Judith K. Wolf | - | 2014 | Member of Scientific Advisory Board |
Calaneet Balas | - | - | Member of Scientific Advisory Board |
Ellen O’Connor Vos | 68 | 2023 | Independent Director |
Leo Twiggs | - | 2023 | Chairman of Clinical Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核